Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goelams 074 Trial: HDT + Rituximab for DLBCL
NCT00965289Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Apr 2002
- Primary completion
- May 2003
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in diffuse large B-cell lymphoma (DLBCL), sponsored by CHU de Nantes. Started Apr 2002; status: completed.
02
Drugs
rituximab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT00965289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00965289.